Oncology & Cancer

Testosterone research brings new hope for cancer patients

Many cancer patients suffer from a loss of body mass known as cachexia. Approximately 20 percent of cancer related deaths are attributed to the syndrome of cachexia, which in cancer patients is often characterized by a rapid ...

Oncology & Cancer

Excess zinc in muscles contributes to wasting syndrome in cancer

It's estimated that nearly one-third of all cancer deaths are caused not by the cancer itself but by cachexia—a debilitating muscle-wasting syndrome that affects an estimated 80 percent of advanced cancer patients. Cachexia ...

Oncology & Cancer

Treating muscle wasting improved cancer survival

Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a ...

Oncology & Cancer

Genes that hold the clues to bladder cancer and its treatment

Scientists have discovered the 'genetic signatures' of the most common form of bladder cancer - and it could open up the possibility of better-targeted treatment, according to research published today (13 November).

page 11 from 23